NPF-NPFR pathway in LNd-LPN feedback circuit fine-tune cooling induced locomotion increase. by Xin Yuan (174619)

“…(E–G) <i>NPF</i> knockdown in LNds (<i>DvPdf-Gal4>Uas-NPF RNAi</i>) blocks low temperature (19°C) induced decrease in evening sleep (ZT6-ZT12). Evening sleep (F) and sleep change (G) were quantified. …”

Inference of cell-type proportions from bulk RNAseq and dynamics during myocardial infarction in α1A-AR-KO mice. by Brian Gural (21781982)

“…<b>(D)</b> Estimation of cardiac cell type composition changes post-myocardial infarction (MI) and in α1A-AR knockout (cmAKO) mice, showing increased proportions of macrophages and fibroblasts and decreased proportions of cardiomyocytes, with more pronounced changes in cmAKO mice. …”

Identifying cyst initiation candidate genes through mRNA sequencing <i>Pkd2</i> mouse kidneys at pre-cystic and early cystic time points. by Abigail O. Smith (11883787)

Differences between outcomes and types of learning during the lockdown and after the pandemic. by Juan-Ignacio Pozo (20421678)

(A) The overexpression of PRDX1 reduces the intracellular ROS level. by Jing Chen (4762)

“…After overexpression of chIRAP, the intensity of red fluorescence in mitochondria decreased significantly, while the green fluorescence increased significantly. …”

Fig S1. by Leonardo Santos (477304)

“…Black arrows indicate the formation of heteroduplexes, which are absent in the controls of uninduced and untransfected cells, as well as in induced but untransfected cells (Ctrl and Ctrl2, respectively). A noticeable decrease in amplicon yield suggests significant modifications following Cas9 cleavage and DNA repair processes. …”

AC-LPN circuit control high temperature induced increase of evening sleep. by Xin Yuan (174619)

“…Quantification of evening sleep (I) and sleep change (J) shown. (K–M) The ppk neuron inhibition also blocks the high-temperature-induced decrease in evening locomotion (ZT9-ZT12) (red bar, 29°C) relative to baseline (black bar, 23°C). …”

Partial behavioral switching. by Hiroyuki Ichijo (13891153)

Clinical data of lymphoma patients. by Runlong Lin (20796909)

“…Moreover, the count of patients with abnormal cardiac uptake significantly rose post-treatment. Analyzing changes in uptake patterns, the group displaying abnormal changes exhibited an increase in left atrial diameter and a decrease in left ventricular ejection fraction compared to the group with normal changes. …”

Differences between reproductive and constructive uses during school lockdown and after the pandemic. by Juan-Ignacio Pozo (20421678)

Classification of Anti-HlyE IgG Responses. by Jo Walker (22404069)

Processed dataset for analysis. by Angela M. Klock (2631601)

“…<div><p>On the global scale, agricultural crop yields have decreased or plateaued over the last several decades. …”

PERCOM, an unbiased and easily-accessible protein-centric analysis workflow. by Brian Foo (19273132)

Statistical analysis of the AUC measurement. by Esra Ayan (21156015)

“…<p>Analysis indicated that INSv application significantly changed spontaneous calcium activity (IAsp <i>p</i>-value: 0.1290, INSv <i>p</i>-value: 0.0002). …”

Effects of activators and inhibitors on TcPiezo channels. by Guozhong Huang (673424)

“…Downregulation of <i>TcPiezo1</i> expression significantly decreased Dooku1-evoked TcPiezo1-mediated Ca²⁺ entry (left bar graph) but had no effect on Dooku1-evoked TcPiezo2-mediated Ca²⁺ release (right bar graph). …”

Individual data. by JoEllen M. Sefton (16880253)

“…The primary outcome measure was change in metabolic cost with/without the exoskeleton (O2 consumption, metabolic equivalents); secondary outcomes were change in heart rate and perceived exertion between conditions.…”

Descriptive statistics. by JoEllen M. Sefton (16880253)

“…The primary outcome measure was change in metabolic cost with/without the exoskeleton (O2 consumption, metabolic equivalents); secondary outcomes were change in heart rate and perceived exertion between conditions.…”

Time matched metabolic cost. by JoEllen M. Sefton (16880253)

“…The primary outcome measure was change in metabolic cost with/without the exoskeleton (O2 consumption, metabolic equivalents); secondary outcomes were change in heart rate and perceived exertion between conditions.…”

Research design. by JoEllen M. Sefton (16880253)

“…The primary outcome measure was change in metabolic cost with/without the exoskeleton (O2 consumption, metabolic equivalents); secondary outcomes were change in heart rate and perceived exertion between conditions.…”

Time matched physiological strain. by JoEllen M. Sefton (16880253)

“…The primary outcome measure was change in metabolic cost with/without the exoskeleton (O2 consumption, metabolic equivalents); secondary outcomes were change in heart rate and perceived exertion between conditions.…”